|
APTO
|
Aptose Biosciences, Inc.
|
US
|
NASDAQ
|
|
BLRX
|
BioLineRx Ltd.
|
US
|
NASDAQ
|
|
CGEM
|
Cullinan Management, Inc.
|
US
|
NASDAQ
|
|
CTIC
|
Cell Therapeutics, Inc.
|
US
|
NASDAQ
|
|
FBIO
|
Fortress Biotech, Inc.
|
US
|
NASDAQ
|
|
HCWB
|
HCW Biologics Inc.
|
US
|
NASDAQ
|
|
PYXS
|
Pyxis Oncology, Inc.
|
US
|
NASDAQ
|
|
SLS
|
SELLAS Life Sciences Group, Inc.
|
US
|
NASDAQ
|
|
TCBP
|
TC BioPharm (Holdings) plc
|
US
|
NASDAQ
|
|
ARGNF
|
Argen X Nv
|
US
|
OTC
|
|
OTLC
|
Oncotelic Therapeutics, Inc
|
US
|
OTC
|
|
38I
|
Intellia Therapeutics Inc
|
DE
|
F
|
|
039200
|
Oscotec Inc
|
KR
|
KQ
|
|
AB
|
AB Science S.A
|
FR
|
PA
|
|
ALCLS
|
Cellectis
|
FR
|
PA
|
|
IMMU
|
Immunicum AB (publ)
|
SE
|
ST
|
|
RVU
|
Ryvu Therapeutics SA
|
PL
|
WAR
|
|
6JH
|
IN8BIO INC. DL-0001
|
DE
|
F
|